PaulFeuerstadtMDFACG
Gastroenterology • Hamden, CTAttending Physician Gastroenterology Center of Connecticut
Dr. Feuerstadt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2200 Whitney Ave
Suite 360
Hamden, CT 06518Phone+1 203-281-4463Fax+1 203-287-2930
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Gastroenterology, 2007 - 2010
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2004 - 2007
Weill Cornell MedicineClass of 2004
Certifications & Licensure
CT State Medical License 2010 - 2025
NY State Medical License 2006 - 2025
FL State Medical License 2014 - 2016- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers Start of enrollment: 2014 Oct 01
Publications & Presentations
PubMed
- 36 citationsPerception of quality of life in people experiencing or having experienced a Clostridioides difficile infection: a US population surveyLise Lurienne, Pierre-Alain Bandinelli, Thibaut Galvain, Charles-Alexis Coursel, Caterina Oneto
Journal of Patient-Reported Outcomes. 2020-02-19 - 158 citationsACG Clinical Guideline: Epidemiology, Risk Factors, Patterns of Presentation, Diagnosis, and Management of Colon Ischemia (CI)Lawrence J. Brandt, Paul Feuerstadt, George F. Longstreth, Scott J. Boley
The American Journal of Gastroenterology. 2015-01-01 - 110 citationsEfficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Rec...Sahil Khanna, Maha Assi, Christine Lee, David Yoho, Thomas Louie
Drugs. 2022-10-01
Authored Content
- C. Difficile Infection at DDW 2023May 2023
Press Mentions
New AGA Podcast Series Explores the Latest in C. DifficileOctober 12th, 2023- VIDEO: Low Risk for Congestive Heart Failure Exacerbation with Zinplava for C. DifficileMay 15th, 2023
- Four Analyses of Data for REBYOTA™ (Fecal Microbiota, Live – Jslm), the First FDA-Approved Microbiome-Based Treatment for the Prevention of Recurrent C. Difficile Infection, Presented at DDW 2023May 8th, 2023
- Join now to see all
Professional Memberships
- Fellow
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
